doi.org/10.1158/1078-0432.ccr-20-4116
Original paper

Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

..., Manuel Hidalgo
85
Clinical Cancer Research10.00
Pages: clincanres.4116.2020 - clincanres.4116.2020
Published: Nov 17, 2021
Abstract
Purpose: Pancreatic ductal adenocarcinoma (PDAC) remains a significant health issue. For most patients there are no options for targeted therapy and existing treatments are limited by toxicity. The HOPE trial (Harnessing Organoids for PErsonalized Therapy) was a pilot feasibility trial aiming to prospectively generate patient derived organoids (PDOs) from patients with PDAC and test their drug sensitivity and correlation with clinical outcomes....
Paper Fields
Paper Details
Title
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer
DOI
doi.org/10.1158/1078-0432.ccr-20-4116
Published Date
Nov 17, 2021
Journal
Clinical Cancer Research
Pages
clincanres.4116.2020 - clincanres.4116.2020
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.